Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Inhibits Breast Cancer Growth

被引：0
|
作者：
Ota, Chikayo
Nomiyama, Takashi
Komatsu, Shiho
Kawanami, Takako
Hamaguchi, Yuriko
Tanaka, Tomoko
Yanase, Toshihiko
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2093-P
引用
收藏
页码：A536 / A536
页数：1
相关论文
共 50 条
  • [1] Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Inhibits Prostate Cancer Growth
    Nomiyama, Takashi
    Kawanami, Takako
    Terawaki, Yuichi
    Tsutsumi, Yoko
    Hamaguchi, Yuriko
    Tanaka, Tomoko
    Murase, Kunitaka
    Yanase, Toshihiko
    DIABETES, 2013, 62 : A512 - A512
  • [2] Combined treatment with glucagon-like peptide-1 receptor agonist exendin-4 and metformin attenuates breast cancer growth
    Yuki Tanaka
    Chikayo Iwaya
    Takako Kawanami
    Yuriko Hamaguchi
    Tsuyoshi Horikawa
    Toru Shigeoka
    Toshihiko Yanase
    Daiji Kawanami
    Takashi Nomiyama
    Diabetology International, 2022, 13 : 480 - 492
  • [3] Combined treatment with glucagon-like peptide-1 receptor agonist exendin-4 and metformin attenuates breast cancer growth
    Tanaka, Yuki
    Iwaya, Chikayo
    Kawanami, Takako
    Hamaguchi, Yuriko
    Horikawa, Tsuyoshi
    Shigeoka, Toru
    Yanase, Toshihiko
    Kawanami, Daiji
    Nomiyama, Takashi
    DIABETOLOGY INTERNATIONAL, 2022, 13 (03) : 480 - 492
  • [4] Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth via Inhibiting NF-kB Activation
    Iwaya, Chikayo
    Nomiyama, Takashi
    Komatsu, Shiho
    Kawanami, Takako
    Hamaguchi, Yuriko
    Tanaka, Tomoko
    Yanase, Toshihiko
    DIABETES, 2017, 66 : A532 - A532
  • [5] Exendin-4, Glucagon-like Peptide-1 Receptor Agonist, Inhibits Cancer Cell Proliferation Depending on GLP-1R Expression
    Nomiyama, Takashi
    Kawanami, Takako
    Terawaki, Yuichi
    Fukuda, Takashi
    Hamaguchi, Yuriko
    Tanaka, Tomoko
    Yanase, Toshihiko
    DIABETES, 2014, 63 : A486 - A486
  • [6] Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line
    Wei, Qian
    Sun, Yu Qiang
    Zhang, Jin
    PEPTIDES, 2012, 37 (01) : 18 - 24
  • [7] Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis
    Marzioni, Marco
    Alpini, Gianfranco
    Saccomanno, Stefania
    Candelaresi, Cinzia
    Venter, Juliet
    Rychlicki, Chiara
    Fava, Giammarco
    Francis, Heather
    Trozzi, Luciano
    Glaser, Shannon
    Benedetti, Antonio
    GASTROENTEROLOGY, 2007, 133 (01) : 244 - 255
  • [8] Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury
    Hirata, Yoichiro
    Kurobe, Hirotsugu
    Nishio, Chika
    Tanaka, Kimie
    Fukuda, Daiju
    Uematsu, Etsuko
    Nishimoto, Sachiko
    Soeki, Takeshi
    Harada, Nagakatsu
    Sakaue, Hiroshi
    Kitagawa, Tetsuya
    Shimabukuro, Michio
    Nakaya, Yutaka
    Sata, Masataka
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 699 (1-3) : 106 - 111
  • [9] Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury
    Goto, Hiromasa
    Nomiyama, Takashi
    Mita, Tomoya
    Yasunari, Eisuke
    Azuma, Kosuke
    Komiya, Koji
    Arakawa, Masayuki
    Jin, Wen Long
    Kanazawa, Akio
    Kawamori, Ryuzo
    Fujitani, Yoshio
    Hirose, Takahisa
    Watada, Hirotaka
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 405 (01) : 79 - 84
  • [10] Indirect Effects of Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 on the Peripheral Circadian Clocks in Mice
    Ando, Hitoshi
    Ushijima, Kentarou
    Fujimura, Akio
    PLOS ONE, 2013, 8 (11):
12345